Skip to main content
BioCentury Innovations
< Next Issue 1 2 3 4 5 Prior Issue >
As published Thursday, July 21, 2016

By Mark Zipkin, Staff Writer

Few in the British life sciences sector voiced support for an exit from the EU before last month's referendum, but academics, industry leaders and investors are now weighing up the actual damage as they face the reality of the new norm. The biggest concern is that the potential loss of research funding and restrictions on movement could lead to another brain drain for the country.

For those invested in building a biotech sector on the back of the U.K.'s academic science, the timing could hardly have been worse.